In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12)

MLA

Robyn L. Tideman, et al. “In Vitro HIV-Specific CTL Activity from HIV-Seropositive Individuals Is Augmented by Interleukin-12 (IL-12).” AIDS Research and Human Retroviruses, vol. 17, no. 3, Feb. 2001. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....00e485e706e5791d29dd7cb97c9f6573&authtype=sso&custid=ns315887.

APA

Robyn L. Tideman, Graeme J. Stewart, David A. Fulcher, Don Packham, Elizabeth M. Benson, Janett D. Clarkson, Tong Liang, Rosemary A. Ffrench, & Judy Young. (2001). In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12). AIDS Research and Human Retroviruses, 17(3).

Chicago

Robyn L. Tideman, Graeme J. Stewart, David A. Fulcher, Don Packham, Elizabeth M. Benson, Janett D. Clarkson, Tong Liang, Rosemary A. Ffrench, and Judy Young. 2001. “In Vitro HIV-Specific CTL Activity from HIV-Seropositive Individuals Is Augmented by Interleukin-12 (IL-12).” AIDS Research and Human Retroviruses 17 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....00e485e706e5791d29dd7cb97c9f6573&authtype=sso&custid=ns315887.